Safeguard Scientifics

Prognos Health is a health tech company focused on healthcare analytics, offering a platform called prognosFACTOR. This innovative platform can quickly query billions of lab and health records from over 325 million de-identified patients, providing answers to clinically relevant healthcare questions in a fraction of the time traditionally required. Prognos Health allows clients to access HIPAA-compliant, patient-centric healthcare data through the Prognos Marketplace, facilitating a range of applications such as cohort design, patient journey studies, and health outcomes analysis. The company's clientele includes 25 of the top 30 pharmaceutical manufacturers and three of the top five health payers, highlighting its significant role in empowering precise decision-making throughout the healthcare landscape.

Syapse, Inc. is a company that develops a precision medicine software platform aimed at improving cancer care through the integration and analysis of diverse clinical, molecular, treatment, and outcomes data. By leveraging real-world evidence, Syapse enables healthcare organizations to collaborate effectively, providing comprehensive patient insights that inform clinical decisions. Its primary offering, the Syapse Learning Health Network, serves as a global data-sharing network that supports oncologists and life sciences collaborators with actionable insights derived from real-world data. Founded in 2008 and headquartered in San Francisco, California, with an additional office in Radnor, Pennsylvania, Syapse works to enhance precision medicine programs and drive impactful outcomes for cancer patients. The company has also established a strategic partnership with Pfizer to further its mission in the field of precision oncology.

Moxe Health specializes in facilitating the bi-directional exchange of clinical data between health plans and provider systems through its innovative clinical data integration platform. The company offers a range of services including risk adjustment, claims denial management, clinical summaries, administrative notifications, and care gap management. By creating an interactive network, Moxe ensures that health systems and health plans can share medical records and crucial patient insights quickly and efficiently, without disrupting clinicians' existing workflows. The platform supports the transition to value-based care by providing automated solutions that enhance access to essential information, allowing organizations to leverage their investments in population health and analytics effectively. Moxe's commitment to neutrality in data connectivity further enhances its value proposition in the healthcare industry.

Moxe Health specializes in facilitating the bi-directional exchange of clinical data between health plans and provider systems through its innovative clinical data integration platform. The company offers a range of services including risk adjustment, claims denial management, clinical summaries, administrative notifications, and care gap management. By creating an interactive network, Moxe ensures that health systems and health plans can share medical records and crucial patient insights quickly and efficiently, without disrupting clinicians' existing workflows. The platform supports the transition to value-based care by providing automated solutions that enhance access to essential information, allowing organizations to leverage their investments in population health and analytics effectively. Moxe's commitment to neutrality in data connectivity further enhances its value proposition in the healthcare industry.

Syapse, Inc. is a company that develops a precision medicine software platform aimed at improving cancer care through the integration and analysis of diverse clinical, molecular, treatment, and outcomes data. By leveraging real-world evidence, Syapse enables healthcare organizations to collaborate effectively, providing comprehensive patient insights that inform clinical decisions. Its primary offering, the Syapse Learning Health Network, serves as a global data-sharing network that supports oncologists and life sciences collaborators with actionable insights derived from real-world data. Founded in 2008 and headquartered in San Francisco, California, with an additional office in Radnor, Pennsylvania, Syapse works to enhance precision medicine programs and drive impactful outcomes for cancer patients. The company has also established a strategic partnership with Pfizer to further its mission in the field of precision oncology.

Trice Medical, Inc. is a company that specializes in developing orthopedic diagnostic devices incorporating camera-enabled and needle-based technologies. Founded in 2011 and based in Malvern, Pennsylvania, Trice Medical aims to enhance orthopedic diagnostics for patients, physicians, and payors by providing immediate, clear answers through its innovative solutions. By enabling micro-invasive procedures that are painless and cosmetically undetectable, the company's products facilitate office-based diagnostic and therapeutic applications. Trice Medical's technology integrates miniaturized optoelectronics, optimizing clinical services and addressing the shortcomings of traditional diagnostic modalities, thereby reducing false readings and overall healthcare costs.

InfoBionic, Inc., founded in 2011 and based in Lowell, Massachusetts, specializes in remote patient monitoring and cardiac diagnostic services through its cloud-based platform, MoMe™. The MoMe System is designed to enhance the detection of cardiac arrhythmias, allowing healthcare providers to access vital patient data anytime and anywhere. By replicating in-hospital telemetry data, the platform streams continuous electrocardiogram, respiration, and motion data to the cloud for real-time analysis. This innovation aims to improve clinical efficiency and patient care, enabling physicians to monitor and treat cardiac complications effectively.

Zipnosis, Inc. is a healthcare company based in Minneapolis, Minnesota, that specializes in virtual care solutions. Founded in 2008, the company operates a platform that connects patients with clinicians through phone and video interviews, facilitating online diagnosis and triage. Zipnosis offers a unique service called ZipTicket, which acts as a healthcare boarding pass, allowing patients to access clinics for in-person assessments or lab tests when necessary. The platform is designed to enhance patient choice and convenience while improving efficiency for healthcare providers. Through its innovative approach, Zipnosis aims to expand access to immediate care and improve clinical outcomes for health organizations.

meQuilibrium provides online stress management solutions tailored for individuals and employees, focusing on enhancing resilience and well-being in the workplace. The platform is unique in its clinical validation, utilizing principles from behavioral psychology, neuroscience, and analytics to offer insights that drive meaningful change in both personal and organizational contexts. Through its assessment and benchmarking tools, meQuilibrium measures resilience and delivers personalized training programs aimed at improving adaptive capacity, agility, and emotional control among employees. This approach supports organizations in fostering a more resilient and productive workforce.

Propeller Health is a mobile platform that offers sensors, mobile apps, analytics, and services to support respiratory health management. The HIPAA compliant platform stores users’ data in a cloud computing infrastructure. The Propeller sensor and mobile application help users learn more about and better manage their asthma, COPD, and respiratory disease. The Propeller sensor attaches to users’ inhalers and wirelessly syncs with their smartphones. It tracks their triggers and symptoms and sends personalized feedback and education to their phones based on the symptoms. Users can see how often they use the medication, and set up medication reminders and alerts. Propeller community enables users to share their Propeller data with their physician and family members. Propeller Health is backed by Safeguard Scientifics, The Social+Capital Partnership, California HealthCare Foundation, and other investors. The platform works with organizations such as Dignity Health, Wyckoff Heights Medical Center, Amerigroup Florida, and the City of Louisville. The system has been featured in The Economist, Washington Post, Fast Company, Wired, and Scientific American. Propeller Health has received TEDMED Innovation Showcase, White House Champion of Change, and Bluetooth Breakthrough Product awards. Propeller Health was launched by David Van Sickle, Greg Tracy, and Mark Gehring and its operations are based in Wisconsin, United States.

Prognos Health is a health tech company focused on healthcare analytics, offering a platform called prognosFACTOR. This innovative platform can quickly query billions of lab and health records from over 325 million de-identified patients, providing answers to clinically relevant healthcare questions in a fraction of the time traditionally required. Prognos Health allows clients to access HIPAA-compliant, patient-centric healthcare data through the Prognos Marketplace, facilitating a range of applications such as cohort design, patient journey studies, and health outcomes analysis. The company's clientele includes 25 of the top 30 pharmaceutical manufacturers and three of the top five health payers, highlighting its significant role in empowering precise decision-making throughout the healthcare landscape.

Syapse, Inc. is a company that develops a precision medicine software platform aimed at improving cancer care through the integration and analysis of diverse clinical, molecular, treatment, and outcomes data. By leveraging real-world evidence, Syapse enables healthcare organizations to collaborate effectively, providing comprehensive patient insights that inform clinical decisions. Its primary offering, the Syapse Learning Health Network, serves as a global data-sharing network that supports oncologists and life sciences collaborators with actionable insights derived from real-world data. Founded in 2008 and headquartered in San Francisco, California, with an additional office in Radnor, Pennsylvania, Syapse works to enhance precision medicine programs and drive impactful outcomes for cancer patients. The company has also established a strategic partnership with Pfizer to further its mission in the field of precision oncology.

QuanticMind is a predictive advertising management software for paid search and social channels. Their Platform is for Smarter Advertising and is the pioneer of predictive advertising management software for paid search and social channels. By reinventing ad management point solutions through machine learning, distributed cloud computing, and in-memory processing, QuanticMind delivers the most intelligent, scalable, and fastest platform for maximizing advertising performance for enterprises. A global community of data-driven marketers relies on QuanticMind’s data science-powered platform to anticipate and execute the best and most granular advertising investments. It was incorporated in 2011 and is headquartered in Redwood City, California.

Trice Medical, Inc. is a company that specializes in developing orthopedic diagnostic devices incorporating camera-enabled and needle-based technologies. Founded in 2011 and based in Malvern, Pennsylvania, Trice Medical aims to enhance orthopedic diagnostics for patients, physicians, and payors by providing immediate, clear answers through its innovative solutions. By enabling micro-invasive procedures that are painless and cosmetically undetectable, the company's products facilitate office-based diagnostic and therapeutic applications. Trice Medical's technology integrates miniaturized optoelectronics, optimizing clinical services and addressing the shortcomings of traditional diagnostic modalities, thereby reducing false readings and overall healthcare costs.

Since its early success in transforming the financial infrastructure for renewable energy, T-REX has become a trusted expert at the center of tech, data, and financial markets—modernizing the technology infrastructure for the asset-backed finance ecosystem. Our platform combines SaaS technology and big data management to deliver a centralized experience for deal modeling, risk analysis, performance tracking, collaboration, and reporting. We’re filling a critical technology gap by digitizing and standardizing data, and automating workflow across the lifecycle of complex deals. T-REX aims to make it easier for capital to flow into complex assets, a key component to unlock potential and accelerate innovation.

CloudMine is a mobile backend-as-a-service (mBaaS) provider that focuses on enhancing healthcare mobility and patient health. The company offers a platform that facilitates object-based data storage and file storage, along with capabilities for sending push notifications and messages, thereby improving communication with users. By streamlining the development process, CloudMine enables healthcare and life science organizations to efficiently operationalize data through application development, analytics, and workflows. The platform is designed to support the creation of secure, interoperable, and scalable healthcare applications, significantly reducing development time and costs while eliminating the need for ongoing maintenance and management of mobile applications. Its mobile-optimized infrastructure and suite of prefabricated web services accelerate app development by up to 70%, standardizing mobility tools across various business units for improved efficiency.

VitalTrax connects patients with clinical trials with its cloud-based clinical trial network. VitalTrax offers Wing, a solution that simplifies clinical trials enrollment. Wing is a clinical trial network that provides innovative ways for people to easily seek optional treatments for themselves or people that they love and play an important role in helping develop new ways to fight diseases.

Velano Vascular, Inc. is a medical device company based in San Francisco, California, established in 2011. The company specializes in the development of needle-free vascular access devices, particularly its FDA-approved PIVO device. This innovative, single-use, and sterile device allows for blood collection from indwelling peripheral IV lines, significantly reducing the need for traditional needle sticks and central line access. Velano Vascular aims to enhance patient care by providing a painless and efficient blood draw option, thereby improving the experience for hospital inpatients while also offering a safer practice for healthcare providers. Additionally, the PIVO device presents a financially responsible alternative for health systems, addressing the challenges associated with conventional vascular access methods.

COSY is an information technology company that specializes in the fields of artificial intelligence, computer vision, machine perception, and software as a service. The company focuses on leveraging University research for enabling industry solutions in computer vision, perception, and artificial intelligence.

Spongecell, Inc. is an advertising technology company based in New York that specializes in creating and managing personalized digital advertisements. Founded in 2006, the company transforms traditional banner ads into interactive formats that can incorporate video, social media, and other engaging features. Its Creative Management Platform enables brands to develop unique ad experiences across display, mobile, and video platforms, leveraging intelligent data integrations and decision-making tools. By streamlining the creative process, Spongecell empowers advertisers and their agencies to execute effective online campaigns that enhance brand engagement and drive performance. The company has received recognition for its innovative approach to programmatic advertising and operates as a subsidiary of Simplicity Marketing Ltd.

Brickwork powers the new Pre-Visit Experience for customers of the world’s leading brands and retailers. Brickwork’s SaaS platform delivers a better pre-visit experience: providing their customers more accurate store information, more access to events and promotions, more personal assistance when they arrive in-store, and more confidence that products are available near them. Brickwork opens a new world of actionable data for marketers and store teams, starting with its unique measure of Digital-to-Store Conversion, to drive traffic, engagement, conversion, and basket size. It was founded in 2013 and is headquartered in New York, New York.

Moxe Health specializes in facilitating the bi-directional exchange of clinical data between health plans and provider systems through its innovative clinical data integration platform. The company offers a range of services including risk adjustment, claims denial management, clinical summaries, administrative notifications, and care gap management. By creating an interactive network, Moxe ensures that health systems and health plans can share medical records and crucial patient insights quickly and efficiently, without disrupting clinicians' existing workflows. The platform supports the transition to value-based care by providing automated solutions that enhance access to essential information, allowing organizations to leverage their investments in population health and analytics effectively. Moxe's commitment to neutrality in data connectivity further enhances its value proposition in the healthcare industry.

MedCrypt Inc. is a cybersecurity company focused on enhancing the security of medical devices. Founded in 2016 and based in Solana Beach, California, it provides data security solutions tailored for a wide range of medical devices, including pacemakers and surgical robots. MedCrypt's platform allows original equipment manufacturers (OEMs) to easily integrate essential security features, such as user authentication, data encryption, and monitoring for potential malicious activity, into their devices. This capability not only protects sensitive health information but also ensures that devices operate only on commands from trusted sources. By streamlining the implementation of these security measures, MedCrypt enables engineers to prioritize the development of innovative clinical functionalities while maintaining robust protection against unauthorized access and misuse.

InfoBionic, Inc., founded in 2011 and based in Lowell, Massachusetts, specializes in remote patient monitoring and cardiac diagnostic services through its cloud-based platform, MoMe™. The MoMe System is designed to enhance the detection of cardiac arrhythmias, allowing healthcare providers to access vital patient data anytime and anywhere. By replicating in-hospital telemetry data, the platform streams continuous electrocardiogram, respiration, and motion data to the cloud for real-time analysis. This innovation aims to improve clinical efficiency and patient care, enabling physicians to monitor and treat cardiac complications effectively.

Aktana Inc. develops AI-enabled marketing decision support software specifically for sales and marketing teams in the life sciences sector. Its primary offerings include the Contextual Intelligence Engine, which allows executives to simulate various call plans and marketing channels, and the Decision Support Engine, which analyzes diverse data sources to provide actionable insights directly within the representatives' workflows. By integrating data-driven suggestions into existing CRM systems, Aktana helps companies refine their strategies and optimize engagement with healthcare professionals. The company's solutions support over 100 brands, including many of the top pharmaceutical companies, by enhancing revenue generation and channel effectiveness. Founded in 2008 and headquartered in San Francisco, Aktana also maintains offices in several global cities, including Tokyo, Shanghai, and Barcelona, positioning itself to understand and address the unique dynamics of the life sciences market.

Noble.MD is a healthcare technology company based in Bryn Mawr, Pennsylvania, founded in 2012. The company develops Theo, a digital healthcare advisory platform designed to assist patients in identifying health and behavioral risks. The platform actively engages patients by providing programs and interventions to help them manage these risks. By capturing essential patient data at the time of care, Noble.MD facilitates value-based reimbursement and aligns the interests of providers and payers, enhancing the processes of risk identification, coding, and management.

Transactis, Inc. specializes in Software-as-a-Service (SaaS) solutions for electronic bill presentment and payment, primarily serving businesses in the United States. The company offers BillerIQ, a cloud-based platform that allows businesses to send electronic bills and invoices while facilitating payments through online, phone, and mobile channels. Additionally, Transactis provides DocumentIQ, a digital document management solution that helps organizations manage and store documents electronically. Its services cater to various sectors, including financial services, healthcare, utilities, education, and retail, among others. Transactis operates through a reseller network that includes financial institutions and technology companies, positioning itself as a comprehensive partner by providing sales, marketing, and operational support to enhance resellers' offerings. The company adheres to stringent regulatory standards, ensuring compliance with industry requirements. Founded in 2001 and headquartered in New York, Transactis operates as a subsidiary of Mastercard Incorporated.

Velano Vascular, Inc. is a medical device company based in San Francisco, California, established in 2011. The company specializes in the development of needle-free vascular access devices, particularly its FDA-approved PIVO device. This innovative, single-use, and sterile device allows for blood collection from indwelling peripheral IV lines, significantly reducing the need for traditional needle sticks and central line access. Velano Vascular aims to enhance patient care by providing a painless and efficient blood draw option, thereby improving the experience for hospital inpatients while also offering a safer practice for healthcare providers. Additionally, the PIVO device presents a financially responsible alternative for health systems, addressing the challenges associated with conventional vascular access methods.

Zipnosis, Inc. is a healthcare company based in Minneapolis, Minnesota, that specializes in virtual care solutions. Founded in 2008, the company operates a platform that connects patients with clinicians through phone and video interviews, facilitating online diagnosis and triage. Zipnosis offers a unique service called ZipTicket, which acts as a healthcare boarding pass, allowing patients to access clinics for in-person assessments or lab tests when necessary. The platform is designed to enhance patient choice and convenience while improving efficiency for healthcare providers. Through its innovative approach, Zipnosis aims to expand access to immediate care and improve clinical outcomes for health organizations.

Cask is an open-source software company based in Palo Alto, California, that specializes in simplifying the development and management of big data solutions. The company offers a unified integration platform that significantly reduces the time required to deploy data applications and data lakes by up to 80%. Cask's platform combines data integration and application development capabilities, allowing customers to accelerate their development processes in both public and private cloud environments. It is supported by notable investors, including Battery Ventures, Andreessen Horowitz, and Ignition Partners.

QuanticMind is a predictive advertising management software for paid search and social channels. Their Platform is for Smarter Advertising and is the pioneer of predictive advertising management software for paid search and social channels. By reinventing ad management point solutions through machine learning, distributed cloud computing, and in-memory processing, QuanticMind delivers the most intelligent, scalable, and fastest platform for maximizing advertising performance for enterprises. A global community of data-driven marketers relies on QuanticMind’s data science-powered platform to anticipate and execute the best and most granular advertising investments. It was incorporated in 2011 and is headquartered in Redwood City, California.

Sonobi, Inc. is an advertising technology company based in Winter Park, Florida, founded in 2011. It offers a platform that connects publishers, advertisers, and media agencies, facilitating the marketing and positioning of advertising opportunities. By utilizing user-centric technology and intelligent data, Sonobi enables clients to drive results and achieve their business goals through more effective advertising strategies. The platform includes tools for both buy and sell sides of the advertising market, allowing users to identify, deliver, and manage advertising opportunities efficiently. Additionally, Sonobi provides a Consent Management Platform, designed to help publishers ensure compliance with privacy regulations while maintaining transparent consent processes. Overall, Sonobi aims to create a fair and equitable media marketplace, fostering better connections between brands and individuals.

Apprenda is a developer of a cloud-based enterprise platform used to power the next generation of enterprise software development. The company creates and supports modern, enterprise-ready application platforms for both cloud-native and traditional application workloads. With more than a decade of deep, enterprise customer insights, it provides compatible solution offerings for both individuals and IT departments, removing friction from the software delivery process and transforming IT into an engine of growth. Apprenda was established in 2007 and is headquartered in Troy, New York.

Pneuron offers a business platform designed to streamline the development, deployment, and management of products, analytics, and operational practices for enterprises. By utilizing its Distributed Platform, Pneuron enables organizations to connect data, applications, and processes directly with their existing systems, eliminating the need for intermediary databases and reducing integration costs. This platform facilitates the management of the entire business solution lifecycle from a single interface, addressing challenges related to complexity, time, and cost. As a result, businesses experience enhanced productivity, improved engagement with their expertise, and lower costs, allowing them to focus on driving innovation and realizing business value.

Clutch serves as a customer marketing platform for business-to-consumer brands. It provides traditional marketing CRM, loyalty, gift card, mobile, email, and direct mail solutions. The company was created to help businesses succeed in an evolving marketing landscape. Since 2012, they have continued to grow their platform into an innovative, data-centric marketing solution with one focus that empowering brands with the best technology so that they can identify, understand and motivate their customers.

Full Measure Education is a Student Lifecycle and Retention Management company developing a student-facing mobile/social/web technology and human-powered retention services that keep students from dropping out of college. Full Measure Education’s cutting edge approach and technology design is the result of lessons learned by its senior management through 10,000,000 plus student help desk interactions at 850 plus colleges and universities. As a result, Full Measure Education has more post-secondary experience with which to deliver extraordinary outcomes in every major benchmark, including retention, enrollment growth, operational efficiencies, and financial aid utilization.

meQuilibrium provides online stress management solutions tailored for individuals and employees, focusing on enhancing resilience and well-being in the workplace. The platform is unique in its clinical validation, utilizing principles from behavioral psychology, neuroscience, and analytics to offer insights that drive meaningful change in both personal and organizational contexts. Through its assessment and benchmarking tools, meQuilibrium measures resilience and delivers personalized training programs aimed at improving adaptive capacity, agility, and emotional control among employees. This approach supports organizations in fostering a more resilient and productive workforce.

CloudMine is a mobile backend-as-a-service (mBaaS) provider that focuses on enhancing healthcare mobility and patient health. The company offers a platform that facilitates object-based data storage and file storage, along with capabilities for sending push notifications and messages, thereby improving communication with users. By streamlining the development process, CloudMine enables healthcare and life science organizations to efficiently operationalize data through application development, analytics, and workflows. The platform is designed to support the creation of secure, interoperable, and scalable healthcare applications, significantly reducing development time and costs while eliminating the need for ongoing maintenance and management of mobile applications. Its mobile-optimized infrastructure and suite of prefabricated web services accelerate app development by up to 70%, standardizing mobility tools across various business units for improved efficiency.

Aventura intelligently orchestrates assets, people, and systems to deliver the right information at the right time based on location and credentials. It locates and re-assigns the closest online printer and uniquely manages print routing to make it easier to detect and fix printing failures. Aventura was formed in 2007 and headquartered in Denver, Colorado.

Velano Vascular, Inc. is a medical device company based in San Francisco, California, established in 2011. The company specializes in the development of needle-free vascular access devices, particularly its FDA-approved PIVO device. This innovative, single-use, and sterile device allows for blood collection from indwelling peripheral IV lines, significantly reducing the need for traditional needle sticks and central line access. Velano Vascular aims to enhance patient care by providing a painless and efficient blood draw option, thereby improving the experience for hospital inpatients while also offering a safer practice for healthcare providers. Additionally, the PIVO device presents a financially responsible alternative for health systems, addressing the challenges associated with conventional vascular access methods.

Trice Medical, Inc. is a company that specializes in developing orthopedic diagnostic devices incorporating camera-enabled and needle-based technologies. Founded in 2011 and based in Malvern, Pennsylvania, Trice Medical aims to enhance orthopedic diagnostics for patients, physicians, and payors by providing immediate, clear answers through its innovative solutions. By enabling micro-invasive procedures that are painless and cosmetically undetectable, the company's products facilitate office-based diagnostic and therapeutic applications. Trice Medical's technology integrates miniaturized optoelectronics, optimizing clinical services and addressing the shortcomings of traditional diagnostic modalities, thereby reducing false readings and overall healthcare costs.

Propeller Health is a mobile platform that offers sensors, mobile apps, analytics, and services to support respiratory health management. The HIPAA compliant platform stores users’ data in a cloud computing infrastructure. The Propeller sensor and mobile application help users learn more about and better manage their asthma, COPD, and respiratory disease. The Propeller sensor attaches to users’ inhalers and wirelessly syncs with their smartphones. It tracks their triggers and symptoms and sends personalized feedback and education to their phones based on the symptoms. Users can see how often they use the medication, and set up medication reminders and alerts. Propeller community enables users to share their Propeller data with their physician and family members. Propeller Health is backed by Safeguard Scientifics, The Social+Capital Partnership, California HealthCare Foundation, and other investors. The platform works with organizations such as Dignity Health, Wyckoff Heights Medical Center, Amerigroup Florida, and the City of Louisville. The system has been featured in The Economist, Washington Post, Fast Company, Wired, and Scientific American. Propeller Health has received TEDMED Innovation Showcase, White House Champion of Change, and Bluetooth Breakthrough Product awards. Propeller Health was launched by David Van Sickle, Greg Tracy, and Mark Gehring and its operations are based in Wisconsin, United States.

Transactis, Inc. specializes in Software-as-a-Service (SaaS) solutions for electronic bill presentment and payment, primarily serving businesses in the United States. The company offers BillerIQ, a cloud-based platform that allows businesses to send electronic bills and invoices while facilitating payments through online, phone, and mobile channels. Additionally, Transactis provides DocumentIQ, a digital document management solution that helps organizations manage and store documents electronically. Its services cater to various sectors, including financial services, healthcare, utilities, education, and retail, among others. Transactis operates through a reseller network that includes financial institutions and technology companies, positioning itself as a comprehensive partner by providing sales, marketing, and operational support to enhance resellers' offerings. The company adheres to stringent regulatory standards, ensuring compliance with industry requirements. Founded in 2001 and headquartered in New York, Transactis operates as a subsidiary of Mastercard Incorporated.

WebLinc is the parent company for the ecommerce platform Workarea Commerce Cloud and Orderbot order management system.The Workarea Commerce Platform's modern, agile technologies empower companies running global, omnichannel commerce operations, and enable retailers to consistently out-pace the competition. Weblinc's two products, Workarea Commerce Platform and Orderbot OMS support a number of highly successful retail and B2B clients including URBN's BHLDN and Terrain brands, Sanrio, The Reformation, STAPLES Canada, Buzzfeed, Live Nation, Woodcraft Supplies, and The Bouqs.

Syapse, Inc. is a company that develops a precision medicine software platform aimed at improving cancer care through the integration and analysis of diverse clinical, molecular, treatment, and outcomes data. By leveraging real-world evidence, Syapse enables healthcare organizations to collaborate effectively, providing comprehensive patient insights that inform clinical decisions. Its primary offering, the Syapse Learning Health Network, serves as a global data-sharing network that supports oncologists and life sciences collaborators with actionable insights derived from real-world data. Founded in 2008 and headquartered in San Francisco, California, with an additional office in Radnor, Pennsylvania, Syapse works to enhance precision medicine programs and drive impactful outcomes for cancer patients. The company has also established a strategic partnership with Pfizer to further its mission in the field of precision oncology.

Lumesis, Inc. is a financial technology company based in Stamford, Connecticut, specializing in Software-as-a-Service solutions for the municipal marketplace. Founded in 2010, the company operates under the DIVER brand, providing a range of regulatory and data solutions tailored to the needs of U.S. banks, broker/dealers, asset managers, insurance companies, hedge funds, and other financial professionals. Its flagship product, DIVER Analytics, offers access to extensive datasets and analytical tools to address challenges such as stale financials and fiscal uncertainty. Additionally, DIVER Advisor supports clients in meeting regulatory requirements related to time-of-trade disclosure and portfolio management. Lumesis also provides DIVER Data Services, which streamlines data aggregation and delivery, allowing clients to access customized datasets efficiently. Through these solutions, Lumesis aims to enhance business efficiency and decision-making within the municipal bond market.

MediaMath, Inc. is a digital advertising technology company that specializes in providing solutions for advertisers globally. Founded in 2007 and headquartered in New York, the company offers its TerminalOne platform, which facilitates data activation, automated execution, and optimization of advertising interactions across various media channels. MediaMath's programmatic marketing platform enhances customer engagement by utilizing predictive audience targeting and machine learning to ensure relevant messaging. In addition to its technology offerings, the company provides professional services that include programmatic strategy, analytics, technology support, and advertising operations, as well as training and certification programs in digital marketing. MediaMath operates additional offices in several cities across the United States and internationally, including London, Madrid, Berlin, Singapore, Tokyo, Sao Paulo, Sydney, Melbourne, and Bengaluru.

Sotera Wireless, Inc. is a medical device company dedicated to the development, marketing and sale of a new generation of comprehensive vital signs monitoring. Sotera’s mission is to improve patient safety by empowering clinicians to detect early signs of deterioration in virtually any care setting and enable early intervention and rapid response, all without limiting the patient’s freedom of movement.

Hoopla is the new way to win for sales, marketing and customer service teams. Hoopla’s team performance software combines modern game mechanics, data analytics and broadcast-quality video in a powerfully simple application that makes it easy for front-line managers to motivate team performance and score more wins. Using Hoopla, managers can quickly create contests, competitions and leaderboards around any CRM metric, and broadcast live performance updates to TV, web and mobile screens throughout the company. Hoopla's Sales Motivation solutions engage the entire company in an exciting, play-to-win culture that delivers measurable gains in team productivity and performance. Founded in 2010, Hoopla is headquartered in Silicon Valley.

Apprenda is a developer of a cloud-based enterprise platform used to power the next generation of enterprise software development. The company creates and supports modern, enterprise-ready application platforms for both cloud-native and traditional application workloads. With more than a decade of deep, enterprise customer insights, it provides compatible solution offerings for both individuals and IT departments, removing friction from the software delivery process and transforming IT into an engine of growth. Apprenda was established in 2007 and is headquartered in Troy, New York.

Dabo Health provides the healthcare community a free platform to view and track improvement in key performance metrics, to collaborate across hospitals and healthcare systems, and to identify and share evidence based best practices in order to save lives. In the era of Big Data, we enlighten individuals, organizations and industries and empower fundamental change at all levels. By combining human-powered insights with raw, objective data, we inform confident decisions and drive efficiencies. Ours is a system that rewards collaboration with innovative ideas that are integral to the progression of humanity. We call it “The Power of Collective Intelligence.” We channel this shared knowledge of passionate professionals to empower progress.

Clutch serves as a customer marketing platform for business-to-consumer brands. It provides traditional marketing CRM, loyalty, gift card, mobile, email, and direct mail solutions. The company was created to help businesses succeed in an evolving marketing landscape. Since 2012, they have continued to grow their platform into an innovative, data-centric marketing solution with one focus that empowering brands with the best technology so that they can identify, understand and motivate their customers.

QuantiaMD operates as a prominent online community and collaboration platform designed specifically for physicians, boasting a membership of 160,000 doctors who exchange real-life clinical experiences swiftly and extensively. This platform enables healthcare organizations to effectively engage with physicians, aligning them towards common objectives that enhance the quality of care provided. By utilizing a combination of social media elements, gamification, and engagement science, QuantiaMD facilitates seamless communication between healthcare companies and physicians. The platform is designed to be user-friendly, secure, and fully mobile, catering to the contemporary needs of medical professionals.

Prognos Health is a health tech company focused on healthcare analytics, offering a platform called prognosFACTOR. This innovative platform can quickly query billions of lab and health records from over 325 million de-identified patients, providing answers to clinically relevant healthcare questions in a fraction of the time traditionally required. Prognos Health allows clients to access HIPAA-compliant, patient-centric healthcare data through the Prognos Marketplace, facilitating a range of applications such as cohort design, patient journey studies, and health outcomes analysis. The company's clientele includes 25 of the top 30 pharmaceutical manufacturers and three of the top five health payers, highlighting its significant role in empowering precise decision-making throughout the healthcare landscape.

Pneuron offers a business platform designed to streamline the development, deployment, and management of products, analytics, and operational practices for enterprises. By utilizing its Distributed Platform, Pneuron enables organizations to connect data, applications, and processes directly with their existing systems, eliminating the need for intermediary databases and reducing integration costs. This platform facilitates the management of the entire business solution lifecycle from a single interface, addressing challenges related to complexity, time, and cost. As a result, businesses experience enhanced productivity, improved engagement with their expertise, and lower costs, allowing them to focus on driving innovation and realizing business value.

Sotera Wireless, Inc. is a medical device company dedicated to the development, marketing and sale of a new generation of comprehensive vital signs monitoring. Sotera’s mission is to improve patient safety by empowering clinicians to detect early signs of deterioration in virtually any care setting and enable early intervention and rapid response, all without limiting the patient’s freedom of movement.

Crescendo Bioscience, Inc. is a molecular diagnostics company based in South San Francisco, California, that specializes in developing quantitative diagnostic tools for rheumatologists managing autoimmune and inflammatory diseases. Founded in 2002, the company focuses on creating and commercializing blood tests, notably Vectra DA, a standardized multi-biomarker test that assesses disease activity in rheumatoid arthritis. These diagnostic and prognostic tools provide physicians with crucial clinical insights, facilitating therapy selection, monitoring, and overall management of patients with rheumatoid arthritis. By offering objective molecular tests and disease information services, Crescendo Bioscience aims to improve patient outcomes in the field of rheumatology.

AppFirst’s is a patented technology that provides a solution for collecting every event across web-scale applications, regardless of the infrastructure type or programming language. With microsecond visibility into all the applications and supporting resources across their shared infrastructure, IT Operations can now deterministically get to the root cause, effectively footprint applications to determine exactly what resources that application requires, and proactively identify when their applications become wobbly. Those responsible for the infrastructure finally have a way to continuously understand the performance of every application running on the shared-resources they own.

Hoopla is the new way to win for sales, marketing and customer service teams. Hoopla’s team performance software combines modern game mechanics, data analytics and broadcast-quality video in a powerfully simple application that makes it easy for front-line managers to motivate team performance and score more wins. Using Hoopla, managers can quickly create contests, competitions and leaderboards around any CRM metric, and broadcast live performance updates to TV, web and mobile screens throughout the company. Hoopla's Sales Motivation solutions engage the entire company in an exciting, play-to-win culture that delivers measurable gains in team productivity and performance. Founded in 2010, Hoopla is headquartered in Silicon Valley.

Good Start Genetics, Inc. is a molecular diagnostics company based in Cambridge, Massachusetts, focused on genetic screening for inherited diseases. Founded in 2007, the company aims to transform reproductive medicine by providing physicians and patients with actionable insights into inherited genetic disorders. Good Start Genetics offers a range of services, including EmbryVu, a preimplantation genetic screening test designed to enhance in vitro fertilization outcomes by identifying suitable embryos for implantation. The company employs advanced next-generation DNA sequencing technology, along with other established genetic screening methods, to deliver high carrier detection rates. Additionally, through its GoodStart Select program, it provides a comprehensive menu of genetic carrier screening tests for both known and novel mutations, all supported by a commitment to customer care and genetic counseling. As of August 2017, Good Start Genetics operates as a subsidiary of Invitae Corporation.

Lumesis, Inc. is a financial technology company based in Stamford, Connecticut, specializing in Software-as-a-Service solutions for the municipal marketplace. Founded in 2010, the company operates under the DIVER brand, providing a range of regulatory and data solutions tailored to the needs of U.S. banks, broker/dealers, asset managers, insurance companies, hedge funds, and other financial professionals. Its flagship product, DIVER Analytics, offers access to extensive datasets and analytical tools to address challenges such as stale financials and fiscal uncertainty. Additionally, DIVER Advisor supports clients in meeting regulatory requirements related to time-of-trade disclosure and portfolio management. Lumesis also provides DIVER Data Services, which streamlines data aggregation and delivery, allowing clients to access customized datasets efficiently. Through these solutions, Lumesis aims to enhance business efficiency and decision-making within the municipal bond market.

Spongecell, Inc. is an advertising technology company based in New York that specializes in creating and managing personalized digital advertisements. Founded in 2006, the company transforms traditional banner ads into interactive formats that can incorporate video, social media, and other engaging features. Its Creative Management Platform enables brands to develop unique ad experiences across display, mobile, and video platforms, leveraging intelligent data integrations and decision-making tools. By streamlining the creative process, Spongecell empowers advertisers and their agencies to execute effective online campaigns that enhance brand engagement and drive performance. The company has received recognition for its innovative approach to programmatic advertising and operates as a subsidiary of Simplicity Marketing Ltd.

Hoopla is the new way to win for sales, marketing and customer service teams. Hoopla’s team performance software combines modern game mechanics, data analytics and broadcast-quality video in a powerfully simple application that makes it easy for front-line managers to motivate team performance and score more wins. Using Hoopla, managers can quickly create contests, competitions and leaderboards around any CRM metric, and broadcast live performance updates to TV, web and mobile screens throughout the company. Hoopla's Sales Motivation solutions engage the entire company in an exciting, play-to-win culture that delivers measurable gains in team productivity and performance. Founded in 2010, Hoopla is headquartered in Silicon Valley.

DriveFactor is a consolidated contractors company that offers a range of insurance telematics technology solutions. The DriveFactor platform is built on a dynamic, scalable architecture, accepting data from any input method and enabling easy sharing with business partners. The team has built its technology and apps for insurance, and applies its expertise to help clients customize telematics solutions to meet their short- and long-term needs. It was founded in 2010 and is based in Glen Allen, Virginia, USA.

Prognos Health is a health tech company focused on healthcare analytics, offering a platform called prognosFACTOR. This innovative platform can quickly query billions of lab and health records from over 325 million de-identified patients, providing answers to clinically relevant healthcare questions in a fraction of the time traditionally required. Prognos Health allows clients to access HIPAA-compliant, patient-centric healthcare data through the Prognos Marketplace, facilitating a range of applications such as cohort design, patient journey studies, and health outcomes analysis. The company's clientele includes 25 of the top 30 pharmaceutical manufacturers and three of the top five health payers, highlighting its significant role in empowering precise decision-making throughout the healthcare landscape.

Putney, Inc. is a pharmaceutical company based in Portland, Maine, specializing in the development and sale of generic prescription medicines for pets. Founded in 2006, the company focuses on creating high-quality, cost-effective drugs that address common health issues in companion animals. Its product line includes veterinary-approved medications such as Enrofloxacin flavored tablets for bacterial infections in dogs and cats, Cefpodoxime Proxetil tablets for treating skin infections in dogs, and Carprofen caplets for pain management in dogs with osteoarthritis. Additionally, Putney offers human-approved pharmaceuticals, including Ampicillin sodium and Amoxicillin. The company markets and distributes its products through a network of veterinary distributors across the United States. As of 2016, Putney operates as a subsidiary of Dechra Pharmaceuticals plc.

NovaSom, Inc. is a privately held diagnostic-service provider for home testing and evaluation of sleep-disordered breathing, which includes the diagnosis of obstructive sleep apnea (OSA). The company is a Medicare-approved Independent Diagnostic Testing Facility (IDTF) and is fully accredited as both an Ambulatory Care Sleep Diagnostic Center and as a Telehealth provider by The Joint Commission. The home testing system manufactured and distributed by NovaSom has FDA clearance for the diagnostic evaluation of OSA in adults. NovaSom has integrated their home sleep testing system into a cloud-based, collaborative patient management platform for physicians and payers. It is based in Glen Burnie, Maryland, the company was incorporated in 1992.

PixelOptics was founded in 2005 as the world's first composite lens company. Their unique and proprietary approach to lens design combines sound lens design principles and well-known, proven lens materials to create entirely new categories of eyeglass lenses.

ThingWorx radically transforms application development for the the connected world, allowing companies to achieve a step change in operational innovation and resource efficiency.

Good Start Genetics, Inc. is a molecular diagnostics company based in Cambridge, Massachusetts, focused on genetic screening for inherited diseases. Founded in 2007, the company aims to transform reproductive medicine by providing physicians and patients with actionable insights into inherited genetic disorders. Good Start Genetics offers a range of services, including EmbryVu, a preimplantation genetic screening test designed to enhance in vitro fertilization outcomes by identifying suitable embryos for implantation. The company employs advanced next-generation DNA sequencing technology, along with other established genetic screening methods, to deliver high carrier detection rates. Additionally, through its GoodStart Select program, it provides a comprehensive menu of genetic carrier screening tests for both known and novel mutations, all supported by a commitment to customer care and genetic counseling. As of August 2017, Good Start Genetics operates as a subsidiary of Invitae Corporation.

Swaptree is a website that allows users to trade books, CDs, DVDs and video games with other users for freeSwaptree.com provides a platform for trading among its customers. The Company offers a site where the user can freely swap new and used DVDs, CDs, video games, and books with other members. Swaptree.com conducts services in the United States.

Molecular Biometrics, Inc., is applying novel metabolomic technologies to develop accurate, non-invasive methodologies for evaluating normal biologic function in health and disease, and for drug discovery and development. The company's proprietary technology is being applied in reproductive health, neurodegenerative disease (Alzheimer's disease and Parkinson's disease), maternal fetal medicine, pulmonary metabolism and edema, and lactate metabolism.

Quinnova Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercial sale of prescription drug products based on dermal drug delivery platforms. It offers HYDRO 40 foam, a dry skin treatment product; tersi foam, a leave-on foam indicated for the treatment of seborrheic dermatitis and tinea versicolor; rinnovi nail system, a prescription nail system that is designed to clean, treat, and protect diseased, damaged, brittle, and ingrown nails; and cleanse and treat, a pad delivery technology system for the treatment of acne. Quinnova Pharmaceuticals, Inc. was founded in 2003 and is based in Newtown, Pennsylvania.

MediaMath, Inc. is a digital advertising technology company that specializes in providing solutions for advertisers globally. Founded in 2007 and headquartered in New York, the company offers its TerminalOne platform, which facilitates data activation, automated execution, and optimization of advertising interactions across various media channels. MediaMath's programmatic marketing platform enhances customer engagement by utilizing predictive audience targeting and machine learning to ensure relevant messaging. In addition to its technology offerings, the company provides professional services that include programmatic strategy, analytics, technology support, and advertising operations, as well as training and certification programs in digital marketing. MediaMath operates additional offices in several cities across the United States and internationally, including London, Madrid, Berlin, Singapore, Tokyo, Sao Paulo, Sydney, Melbourne, and Bengaluru.

Avid Radiopharmaceuticals is a biopharmaceutical company based in Philadelphia, PA, focused on developing molecular imaging agents designed to improve the medical management of chronic diseases. The company aims to create innovative imaging compounds that can detect and monitor the early stages of pathological changes, facilitating earlier diagnoses and enhancing the management of treatment options. One of their key products, Amyvid, serves as an imaging tool for positron emission tomography, specifically targeting the detection of beta-amyloid plaques in the brain, which is crucial for understanding conditions like Alzheimer's disease. Avid's mission underscores their commitment to transforming disease management through advanced imaging technologies.

Updater’s Home Services Division provides innovative technology that simplifies the purchase of home subscription products across telecommunications, cable, satellite, home security, home improvement, and home energy.

Garnet BioTherapeutics is a clinical stage, venture-backed cell therapy company focused on dermal-based regenerative therapy.

Tengion is a clinical-stage biotechnology company focused on regenerative medicine, specializing in the development of neo-organs and neo-tissues derived from a patient's own cells. The company has successfully completed two Phase 2 clinical trials in the United States for its Tengion Neo-Bladder Augment, aimed at treating children with neurogenic bladder due to spina bifida and adults with neurogenic bladder resulting from spinal cord injury. Tengion's innovative approach seeks to eliminate the need for donor organs or anti-rejection medications by creating living cellular products that can regenerate or replace damaged tissues and organs. Additionally, the company has an investigational new drug application for its Neo-Urinary Conduit and plans to initiate a Phase 1 clinical trial for bladder cancer patients requiring bladder removal. Through its proprietary technology, Tengion aims to enhance patient outcomes by offering alternative solutions for organ and tissue repair.

Molecular Biometrics, Inc., is applying novel metabolomic technologies to develop accurate, non-invasive methodologies for evaluating normal biologic function in health and disease, and for drug discovery and development. The company's proprietary technology is being applied in reproductive health, neurodegenerative disease (Alzheimer's disease and Parkinson's disease), maternal fetal medicine, pulmonary metabolism and edema, and lactate metabolism.

Swaptree is a website that allows users to trade books, CDs, DVDs and video games with other users for freeSwaptree.com provides a platform for trading among its customers. The Company offers a site where the user can freely swap new and used DVDs, CDs, video games, and books with other members. Swaptree.com conducts services in the United States.

NuPathe Inc. is a specialty pharmaceutical company focused on innovative neuroscience solutions for diseases of the central nervous system including neurological and psychiatric disorders. NuPathe's lead product candidate, NP101, is an active, single-use, transdermal sumatriptan patch being developed for the treatment of migraine. In addition to NP101, NuPathe has two proprietary product candidates based on its LAD™, or Long-Acting Delivery, biodegradable implant technology that allows delivery of therapeutic levels of medication over a period of months with a single dose. NP201, for the continuous symptomatic treatment of Parkinson's disease, utilizes a leading FDA-approved dopamine agonist, ropinirole, and is being developed to provide up to two months of continuous delivery. NP202, for the long-term treatment of schizophrenia and bipolar disorder, is being developed to address the long-standing problem of patient noncompliance by providing three months of continuous delivery of risperidone, an atypical antipsychotic. NuPathe is actively seeking partnerships to maximize the commercial potential for its product candidates in the U.S. and territories throughout the world.

Portico's technology enables healthcare organizations to design, build, service and provide value-based reimbursement to their complex provider networks. It also provides the ability to align and automate key network management activities including, provider enrollment, credentialing, contracting and pricing.

Alverix specializes in point-of-care diagnostics technology, focusing on the design and manufacture of low-cost, handheld reader devices that deliver laboratory-level accuracy and precision. The company collaborates with diagnostic and OEM manufacturers to enhance test accuracy, improve portability, and develop new assays suitable for various settings, including physician offices, laboratory outreach, retail clinics, and home use. Alverix emphasizes strong product design, development, and high-volume manufacturing capabilities, positioning itself at the forefront of shifting diagnostic testing from traditional laboratories to locations where rapid results are essential for effective patient care.

Updater’s Home Services Division provides innovative technology that simplifies the purchase of home subscription products across telecommunications, cable, satellite, home security, home improvement, and home energy.

Cellumen is the innovator in cellular systems biology (CSB™) solutions providing the most accurate predictions of drug efficacy and safety, thus reducing failure rates and cutting development costs. Cellumen’s CSB solutions are driving Discovery Toxicology by addressing the full complexity of disease and safety. Leading global organizations, such as the Mayo Clinic, Hamamatsu Photonics K.K., the EPA, FDA, NIH and top pharmaceutical companies, partner with Cellumen. Cellumen is a partner company of Safeguard Scientifics.

Avid Radiopharmaceuticals is a biopharmaceutical company based in Philadelphia, PA, focused on developing molecular imaging agents designed to improve the medical management of chronic diseases. The company aims to create innovative imaging compounds that can detect and monitor the early stages of pathological changes, facilitating earlier diagnoses and enhancing the management of treatment options. One of their key products, Amyvid, serves as an imaging tool for positron emission tomography, specifically targeting the detection of beta-amyloid plaques in the brain, which is crucial for understanding conditions like Alzheimer's disease. Avid's mission underscores their commitment to transforming disease management through advanced imaging technologies.

Authentium, Inc. provides security software and services. It offers SafeCentral, a secure Internet that is designed to enable protected e-commerce; and Command Antivirus, an antivirus product. The company's technologies are used by software providers. Authentium, Inc. was founded in 1999 and is based in Palm Beach Gardens, Florida.

Beyond.com, Inc. operates an online career network to connect job seekers and employers through career channels, and industry and regional communities. Beyond.com, it’s all about focus – and results. You identify the candidates you want to reach, and we’ll help you target them through relevant industry, local and specialty channels. Using our precise targeting abilities, we are able to deliver quality results through recruitment advertising, email marketing, mobile and social channels, and other highly effective tactics. A focused search means more qualified candidates. Get started today, with Beyond.com.

Advanced BioHealing is an industry leader in the science of regenerative medicine. The Company is focused on the commercialization of cell-based and tissue-engineered products. It currently markets the FDA-approved product Dermagraft®, for diabetic foot ulcers. Additionally, the Company's development pipeline includes a next-generation bioengineered tissue product which is in clinical trials. ABH is a privately held company with research & development offices in New York, NY and manufacturing operations in La Jolla, CA.

Advantedge Healthcare Solutions, Inc. designs and develops software for the healthcare industry. The company offers medical billing software. Additionally, it provides radiology, cardiology, anesthesia and pain management, neonatology, internal medicine, and multi specialty medical billing services. The company also offers revenue cycle management services to physicians and medical billing companies. It caters to hospitals and office based specialty physician practices. Advantedge Healthcare Solutions, Inc. was founded in 1999 and is based in Warren, New Jersey.

Portico's technology enables healthcare organizations to design, build, service and provide value-based reimbursement to their complex provider networks. It also provides the ability to align and automate key network management activities including, provider enrollment, credentialing, contracting and pricing.

NuPathe Inc. is a specialty pharmaceutical company focused on innovative neuroscience solutions for diseases of the central nervous system including neurological and psychiatric disorders. NuPathe's lead product candidate, NP101, is an active, single-use, transdermal sumatriptan patch being developed for the treatment of migraine. In addition to NP101, NuPathe has two proprietary product candidates based on its LAD™, or Long-Acting Delivery, biodegradable implant technology that allows delivery of therapeutic levels of medication over a period of months with a single dose. NP201, for the continuous symptomatic treatment of Parkinson's disease, utilizes a leading FDA-approved dopamine agonist, ropinirole, and is being developed to provide up to two months of continuous delivery. NP202, for the long-term treatment of schizophrenia and bipolar disorder, is being developed to address the long-standing problem of patient noncompliance by providing three months of continuous delivery of risperidone, an atypical antipsychotic. NuPathe is actively seeking partnerships to maximize the commercial potential for its product candidates in the U.S. and territories throughout the world.

Rubicor Medical is develops and distributes technologically advanced, disposable, non-invasive, breast biopsy devices.

Authentium, Inc. provides security software and services. It offers SafeCentral, a secure Internet that is designed to enable protected e-commerce; and Command Antivirus, an antivirus product. The company's technologies are used by software providers. Authentium, Inc. was founded in 1999 and is based in Palm Beach Gardens, Florida.

NexTone Communications, headquartered in Rockville, Md., is focused on delivering Internet-based solutions for voice and data convergence to service providers. NexTone is in touch with the needs of the communications industry and is building products and solutions that facilitate the delivery of next generation applications. NexTone Communication's solutions represent what's next in convergence.